240
Participants
Start Date
March 25, 2019
Primary Completion Date
May 23, 2019
Study Completion Date
May 23, 2019
Diagnostic Test: Limited Echocardiogram
STUDY SOFTWARE non-significant risk (NSR) Bay Labs EchoGPS software interfaced with the Terason uSmart 3200t FDA 510(k)-cleared, commercially available ultrasound EchoGPS software communicates with the ultrasound image formation engine of the 510(k)-cleared Terason uSmart 3200t through an application programming interface (API). EchoGPS will be used to provide visual guidance feedback to users during image acquisition. For this study, RNs will use EchoGPS to perform limited echocardiogram examinations.
Minneapolis Heart Institute, Minneapolis
Northwestern Medicine, Bluhm Cardiovascular Institute, Chicago
Sara Guttas
INDUSTRY